Publications

  1. McBane RD, McBane Ii R, Loprinzi CL, Ashrani A, Perez-Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Le-Rademacher JG, Wysokinski WE. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial. Thromb Haemost. 2017 Oct 05; 117 (10):1952-1961 Epub 2017 Aug 24
    View PubMed
  2. Cohoon KP, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is Infection an Independent Risk Factor for Venous Thromboembolism? a Population-Based Case-Control Study. Am J Med. 2017 Oct 04 [Epub ahead of print]
    View PubMed
  3. Marshall AL, Perez Botero J, Ashrani AA, Pruthi RK, Heit JA, Chintakuntlawar A, Guenther JC, Patnaik MM. The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making. J Womens Health (Larchmt). 2017 Sep 21 Epub 2017 Sept 21
    View PubMed
  4. Park MS, Spears GM, Bailey KR, Xue A, Ferrara MJ, Headlee A, Dhillon SK, Jenkins DH, Zietlow SP, Harmsen WS, Ashrani AA, Heit JA. Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: A prospective cohort study. J Trauma Acute Care Surg. 2017 Sep; 83 (3):381-387
    View PubMed
  5. Marshall AL, Durani U, Bartley A, Hagen CE, Ashrani A, Rose C, Go RS, Pruthi RK. The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample-based analysis. Am J Obstet Gynecol. 2017 Sep; 217 (3):344.e1-344.e6 Epub 2017 May 11
    View PubMed
  6. Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood. 2017 Jul 13; 130 (2):109-114 Epub 2017 May 08
    View PubMed
  7. Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis. Vasc Med. 2017 Apr; 22: (2)121-127.
    View PubMed
  8. Alsammak MS, Ashrani AA, Winters JL, Pruthi RK. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency. J Clin Apher. 2017 Mar 15;
    View PubMed
  9. Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost. 2017 Jan 26; 117 (2):390-400 Epub 2016 Dec 15
    View PubMed
  10. Rugeri L, Ashrani AA, Nichols WL, Trousdale RT, Pruthi RK. A single-centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature. Haemophilia. 2016 Nov; 22: (6)934-942.
    View PubMed
  11. Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, Hashmi SK, Marshall AL, Ashrani AA, Dispenzieri A, Kyle RA, Rajkumar SV, Go RS. Prevalence, incidence and survival of smoldering multiple myeloma in the United States. Blood Cancer J. 2016 Oct 21; 6: (10)e486.
    View PubMed
  12. Partain DK, Botero JP, Shi M, Poterucha JJ, Ashrani AA, Thompson CA. Spur cell anemia in the setting of progressive liver allograft failure. Am J Hematol. 2016 Oct; 91: (10)1061.
    View PubMed
  13. Cohoon KP, Ransom JE, Leibson CL, Ashrani AA, Petterson TM, Long KH, Bailey KR, Heit JA. Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study. Am J Med. 2016 Sep; 129 (9):1000.e15-25 Epub 2016 Mar 21
    View PubMed
  14. Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thome SD, Hook CC, Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clin Proc. 2016 Sep; 91: (9)1189-211.
    View PubMed
  15. Park MS, Perkins SE, Spears GM, Ashrani AA, Leibson CL, Boos CM, Harmsen WS, Jenkins DH, Bailey KR, Ballman KV, Heit JA. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study. Thromb Res. 2016 Aug; 144:40-5.
    View PubMed
  16. Bott-Kitslaar DM, Saadiq RA, McBane RD, Loprinzi CL, Ashrani AA, Ransone TR, Wolfgram AA, Berentsen MM, Wysokinski WE. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry. Am J Med. 2016 Jun; 129: (6)615-9.
    View PubMed
  17. Perez Botero J, Ormsby WD, Ashrani AA, McBane RD 2nd, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. Eur J Intern Med. 2016 May; 30:77-81.
    View PubMed
  18. Ashrani AA, Gullerud RE, Petterson TM, Marks RS, Bailey KR, Heit JA. Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res. 2016 Mar; 139:29-37.
    View PubMed
  19. Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw. 2015 Sep; 13: (9)1079-95.
    View PubMed
  20. Heit JA, Lahr BD, Ashrani AA, Petterson TM, Bailey KR. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015 Aug; 136: (2)298-307.
    View PubMed
  21. Ashrani AA. Pulmonary Infarction Manifesting as a Cavitary Lesion. Mayo Clin Proc. 2015 Aug; 90: (8)1170.
    View PubMed
  22. Ashrani AA, Barsoum MK, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Thromb Res. 2015 Jun; 135: (6)1110-6.
    View PubMed
  23. Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Petterson TM, Long KH, Bailey KR, Heit JA. Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care. 2015 Apr 01; 21: (4)e255-63.
    View PubMed
  24. Petterson TM, Marks RS, Ashrani AA, Bailey KR, Heit JA. Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res. 2015 Mar; 135: (3)472-8.
    View PubMed
  25. Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Park MS, Petterson TM, Long KH, Bailey KR, Heit JA. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery. 2015 Mar; 157: (3)423-31.
    View PubMed
  26. Barbara DW, McKenzie KM, Parikh SA, Ashrani AA, Pruthi RK, Burkhart HM, Suri RM, Mauermann WJ. Successful Perioperative Management of Severe Bleeding From Undiagnosed Acquired Factor VIII Inhibitors. J Cardiothorac Vasc Anesth. 2015; 29: (3)731-4.
    View PubMed
  27. Perez Botero J, Spoon DB, Patnaik MS, Ashrani AA, Trousdale RT, Pruthi RK. Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study. Thromb Res. 2015 Jan; 135(1):109-13. Epub 2014 Nov 18.
    View PubMed
  28. Gatt A, Chen D, Pruthi RK, Kamath PS, Leise MD, Ashrani AA, Nichols WL, He R. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective. Semin Thromb Hemost. 2014 Nov; 40(8):845-51. Epub 2014 Nov 13.
    View PubMed
  29. Leibson CL, Petterson TM, Smith CY, Bailey KR, Emerson JA, Ashrani AA, Takahashi PY, Heit JA. Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest. 2014 Aug; 146: (2)412-421.
    View PubMed
  30. Chee CE, Ashrani AA, Marks RS, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood. 2014 Jun 19; 123: (25)3972-8.
    View PubMed
  31. Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, Specks U. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):301-10.
    View PubMed
  32. Froehling DA, Daniels PR, Mauck KF, Collazo-Clavell ML, Ashrani AA, Sarr MG, Petterson TM, Heit JA. Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study. Obes Surg. 2013 Nov; 23(11):1874-9.
    View PubMed
  33. Mauck KF, Froehling DA, Daniels PR, Dahm DL, Ashrani AA, Crusan DJ, Petterson TM, Bailey KR, Heit JA. Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. J Thromb Haemost. 2013 Jul; 11: (7)1279-86.
    View PubMed
  34. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma. 2013 Jun; 54(6):1263-7. Epub 2012 Nov 19.
    View PubMed
  35. Leibson CL, Petterson TM, Smith CY, Bailey KR, Ashrani AA, Heit JA. Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc. 2012 Sep; 60: (9)1718-23.
    View PubMed
  36. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook C, Kaufmann SH, Pruthi RK, Pardanani A, Begna KH, Ashrani AA, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy. Eur J Haematol. 2012 Mar; 88(3):237-43. Epub 2011 Nov 17.
    View PubMed
  37. Heit JA, Lahr BD, Petterson TM, Bailey KR, Ashrani AA, Melton LJ 3rd. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood. 2011 Nov 03; 118: (18)4992-9.
    View PubMed
  38. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook CC, Pruthi R, Kaufmann SH, Pardanani AD, Begna K, Ashrani A, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia (t-APL): Observations on APL pathogenesis. J Clin Oncol. 2011 May 20; 29: (15_suppl)6567.
    View PubMed
  39. Tafur AJ, Kalsi H, Wysokinski WE, McBane RD, Ashrani AA, Marks RS, Crusan DJ, Petterson TM, Bailey KR, Heit JA. The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc. 2011 Jan; 86: (1)25-30.
    View PubMed
  40. Sumekar TA, Ashrani AA, Winarni TI, Hagerman RJ. Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. Case Reports in Genetics. 2011.
  41. Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010 Nov; 126: (5)373-8.
    View PubMed
  42. Ashrani AA, Silverstein MD, Rooke TW, Lahr BD, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study. Vasc Med. 2010 Oct; 15: (5)387-97.
    View PubMed
  43. Naina HV, Patnaik MM, Ali UA, Chen D, Ashrani AA. Systemic fibrinolysis caused by tissue plasminogen activator-producing metastatic breast cancer. J Clin Oncol. 2010 Apr 10; 28(11):e167-8. Epub 2010 Jan 11.
    View PubMed
  44. Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009 Nov; 28: (4)465-76.
    View PubMed
  45. Ashrani AA, Silverstein MD, Lahr BD, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA. Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med. 2009 Nov; 14: (4)339-49.
    View PubMed
  46. Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ 3rd. Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol. 2009 Sep; 29: (9)1399-405.
    View PubMed
  47. Ashrani AA, Rajkumar SV. Chemotherapy-associated thrombosis. Cancer Treat Res. 2009; 148:181-206.
    View PubMed
  48. Ashrani AA, Heit JA. Risk factors for thrombosis in cancer patients. Cancer Treat Res. 2009; 148:95-114.
    View PubMed
  49. Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S, Universal Data Collection Project Investigators. Septic arthritis in males with haemophilia. Haemophilia. 2008 May; 14: (3)494-503.
    View PubMed
  50. Ashrani AA, Reding MT, Shet A, Osip J, Humar A, Lake JR, Key NS. Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor. Haemophilia. 2004 Nov; 10(6):735-7.
    View PubMed
  51. Ashrani AA, Osip J, Christie B, Key NS. Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre. Haemophilia. 2003 Nov; 9(6):721-6.
    View PubMed
  52. Ashrani AA, Aysola A, Al-Khatib H, Nichols WL, Key NS. Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol. 2003 May; 121(4):639-42.
    View PubMed
  53. Bloom SH, Coad JE, Greeno EW, Ashrani AA, Hammerschmidt DE. Cholecystitis as the presenting manifestation of acute myeloid leukemia: report of a case. Am J Hematol. 2002 Jul; 70(3):254-6.
    View PubMed
  54. Ashrani AA, Reding MT, Greeno EW, Shet A, Key NS. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia. Haemophilia. 2002 Jan; 8(1):56-8.
    View PubMed
  55. Ashrani A, Keshavarzian A, Jacyno M, Winship D, Fields JZ. Are dipyridamole (sensitive) calcium channels present in esophageal smooth muscle? Life Sci. 1997; 60(26):PL423-30.
    View PubMed